Controversies in metastatic hormone‐sensitive prostate cancer
Cancer · 15.08.2025 · 131 (16)
DOI: 10.1002/cncr.70030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer, online erschienen am 07.08.2025. Verfasst von Irene Tsung und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Metastatic hormone‐sensitive prostate cancer (mHSPC) is an incurable phase of prostate cancer. Diagnostic tools and management strategies for this complex disease are expanding. Despite these advances, more therapies may not be the optimal approach for all patients. This review explores four major controversies surrounding mHSPC management—the role of prostate‐specific membrane antigen positron emission tomography scans as diagnostic imaging, triplet therapy (androgen deprivation therapy, androgen receptor pathway inhibitor, and docetaxel chemotherapy), radiation to the prostate and/or oligo‐metastases, and bone modifying agents. Critical evaluation of the data emphasizes the need for further work to determine which subgroups of patients with mHSPC benefit from each treatment. With a deeper understanding of these current issues, this review seeks to guide clinicians to refine their clinical practice to help patients achieve their best quantity and quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Irene Tsung, Sarah E Yentz, Zachery R Reichert
Zitieren
APA
Tsung, I., Yentz, S. E., & Reichert, Z. R. (2025). Controversies in metastatic hormone‐sensitive prostate cancer. Cancer, 131(16). https://doi.org/10.1002/cncr.70030
Vancouver
Tsung I, Yentz SE, Reichert ZR. Controversies in metastatic hormone‐sensitive prostate cancer. Cancer. 2025;131(16). doi:10.1002/cncr.70030
BibTeX
@article{Tsung2025,
author = {Tsung, Irene and Yentz, Sarah E and Reichert, Zachery R},
title = {Controversies in metastatic hormone‐sensitive prostate cancer},
journal = {Cancer},
year = {2025},
volume = {131},
number = {16},
doi = {10.1002/cncr.70030}
}
EUVIMED